268 related articles for article (PubMed ID: 32453413)
1. Monolysocardiolipin (MLCL) interactions with mitochondrial membrane proteins.
Duncan AL
Biochem Soc Trans; 2020 Jun; 48(3):993-1004. PubMed ID: 32453413
[TBL] [Abstract][Full Text] [Related]
2. Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts.
Mejia EM; Zegallai H; Bouchard ED; Banerji V; Ravandi A; Hatch GM
J Biol Chem; 2018 May; 293(20):7564-7577. PubMed ID: 29563154
[TBL] [Abstract][Full Text] [Related]
3. Molecular Dynamics Analysis of Cardiolipin and Monolysocardiolipin on Bilayer Properties.
Boyd KJ; Alder NN; May ER
Biophys J; 2018 May; 114(9):2116-2127. PubMed ID: 29742405
[TBL] [Abstract][Full Text] [Related]
4. Cardiolipin, and not monolysocardiolipin, preferentially binds to the interface of complexes III and IV.
Corey RA; Harrison N; Stansfeld PJ; Sansom MSP; Duncan AL
Chem Sci; 2022 Nov; 13(45):13489-13498. PubMed ID: 36507170
[TBL] [Abstract][Full Text] [Related]
5. Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis.
Valianpour F; Mitsakos V; Schlemmer D; Towbin JA; Taylor JM; Ekert PG; Thorburn DR; Munnich A; Wanders RJ; Barth PG; Vaz FM
J Lipid Res; 2005 Jun; 46(6):1182-95. PubMed ID: 15805542
[TBL] [Abstract][Full Text] [Related]
6. Aberrant cardiolipin metabolism is associated with cognitive deficiency and hippocampal alteration in tafazzin knockdown mice.
Cole LK; Kim JH; Amoscato AA; Tyurina YY; Bay R H; Karimi B; Siddiqui TJ; Kagan VE; Hatch GM; Kauppinen TM
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3353-3367. PubMed ID: 30055293
[TBL] [Abstract][Full Text] [Related]
7. Human trifunctional protein alpha links cardiolipin remodeling to beta-oxidation.
Taylor WA; Mejia EM; Mitchell RW; Choy PC; Sparagna GC; Hatch GM
PLoS One; 2012; 7(11):e48628. PubMed ID: 23152787
[TBL] [Abstract][Full Text] [Related]
8. Cellular functions of cardiolipin in yeast.
Joshi AS; Zhou J; Gohil VM; Chen S; Greenberg ML
Biochim Biophys Acta; 2009 Jan; 1793(1):212-8. PubMed ID: 18725250
[TBL] [Abstract][Full Text] [Related]
9. Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function.
Ye C; Shen Z; Greenberg ML
J Bioenerg Biomembr; 2016 Apr; 48(2):113-23. PubMed ID: 25432572
[TBL] [Abstract][Full Text] [Related]
10. Identification of the human mitochondrial linoleoyl-coenzyme A monolysocardiolipin acyltransferase (MLCL AT-1).
Taylor WA; Hatch GM
J Biol Chem; 2009 Oct; 284(44):30360-71. PubMed ID: 19737925
[TBL] [Abstract][Full Text] [Related]
11. Monolysocardiolipin in cultured fibroblasts is a sensitive and specific marker for Barth Syndrome.
van Werkhoven MA; Thorburn DR; Gedeon AK; Pitt JJ
J Lipid Res; 2006 Oct; 47(10):2346-51. PubMed ID: 16873891
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylglycerol Incorporates into Cardiolipin to Improve Mitochondrial Activity and Inhibits Inflammation.
Chen WW; Chao YJ; Chang WH; Chan JF; Hsu YH
Sci Rep; 2018 Mar; 8(1):4919. PubMed ID: 29559686
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial monolysocardiolipin acyltransferase is elevated in the surviving population of H9c2 cardiac myoblast cells exposed to 2-deoxyglucose-induced apoptosis.
Danos M; Taylor WA; Hatch GM
Biochem Cell Biol; 2008 Feb; 86(1):11-20. PubMed ID: 18364741
[TBL] [Abstract][Full Text] [Related]
14. Barth syndrome cells display widespread remodeling of mitochondrial complexes without affecting metabolic flux distribution.
Chatzispyrou IA; Guerrero-Castillo S; Held NM; Ruiter JPN; Denis SW; IJlst L; Wanders RJ; van Weeghel M; Ferdinandusse S; Vaz FM; Brandt U; Houtkooper RH
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3650-3658. PubMed ID: 30251684
[TBL] [Abstract][Full Text] [Related]
15. SS-31 treatment ameliorates cardiac mitochondrial morphology and defective mitophagy in a murine model of Barth syndrome.
Russo S; De Rasmo D; Rossi R; Signorile A; Lobasso S
Sci Rep; 2024 Jun; 14(1):13655. PubMed ID: 38871974
[TBL] [Abstract][Full Text] [Related]
16. Loss of tafazzin results in decreased myoblast differentiation in C2C12 cells: A myoblast model of Barth syndrome and cardiolipin deficiency.
Lou W; Reynolds CA; Li Y; Liu J; Hüttemann M; Schlame M; Stevenson D; Strathdee D; Greenberg ML
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Aug; 1863(8):857-865. PubMed ID: 29694924
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial membrane lipid remodeling in pathophysiology: a new target for diet and therapeutic interventions.
Monteiro JP; Oliveira PJ; Jurado AS
Prog Lipid Res; 2013 Oct; 52(4):513-28. PubMed ID: 23827885
[TBL] [Abstract][Full Text] [Related]
18. Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome.
Angelini R; Russo S; Corcelli A; Lobasso S
J Vis Exp; 2022 Mar; (181):. PubMed ID: 35404345
[TBL] [Abstract][Full Text] [Related]
19. Group VIA phospholipase A2 mitigates palmitate-induced β-cell mitochondrial injury and apoptosis.
Song H; Wohltmann M; Tan M; Ladenson JH; Turk J
J Biol Chem; 2014 May; 289(20):14194-210. PubMed ID: 24648512
[TBL] [Abstract][Full Text] [Related]
20. Deletion of the cardiolipin-specific phospholipase Cld1 rescues growth and life span defects in the tafazzin mutant: implications for Barth syndrome.
Ye C; Lou W; Li Y; Chatzispyrou IA; Hüttemann M; Lee I; Houtkooper RH; Vaz FM; Chen S; Greenberg ML
J Biol Chem; 2014 Feb; 289(6):3114-25. PubMed ID: 24318983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
